The AONYS® platform is able to formulate water soluble active ingredients of various sizes such as metal ions, chelating molecules, peptides and oligonucleotides. In addition, stable ultra-small nanoparticles may be manufactured in situ, opening up new opportunities in the field of nano-medicine.

Therapeutic areas under development:

  • Neurodegenerative diseases with lithium ion
    • Alzheimer’s disease
    • Huntington’s disease
  • Type 2 diabetes and complications of metabolic syndrome with vanadyl ion
  • Decorporation of plutonium with chelating molecules
  • Decorporation of cesium with chelating molecules
  • Radioprotection and radiomitigation after nuclear irradiation

Research therapeutic areas:

  • Customized treatment of resistant cancers with siRNAs and peptides
  • Treatment of Huntington’s disease with peptides
Share:Share on Facebook